Company news
Nexien BioPharma, Inc. news in 2019
Nexien BioPharma, Inc.'s news releases, calls and decks from 2019, newest first.
Nexien BioPharma announces that it has been granted a patent by the Israeli Patent Office covering the use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity - two common nerve agents
July 18, 2019
Nexien BioPharma to Present at The MicroCap Conference Spring Investor Summit on Tuesday, April 2nd
March 27, 2019
Nexien BioPharma Announces Acceptance of Patent Application No. 238946 by Israeli Patent Office
March 5, 2019
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
February 26, 2019
Nexien BioPharma Announces Executive and Business Updates
February 19, 2019
Decks in 2019
- Investor Presentation (March 2019)
Investor deck · 33 slides · March 2019